// App-Quantinova.ai

: Prediction of drop-out and functional impairment in recent-onset schizophrenia spectrum disorders

Researchers

Presenter

  • A. Mucci

Principal Investigators

  • P. Bucci

  • I. Winter Van Rossum

  • C. Arango

  • L. Baandrup

  • B. Glenthøj

  • P. Dazzan

  • A. Demjaha

  • P. Mcguire

  • C. Martínez Díaz-Caneja

  • S. Leucht

  • R. Rodriguez-Jimenez

  • R. Kahn

  • S. Galderisi

Medical Centers

  • Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, London, United Kingdom

  • Gastroenterology Unit, Hospital General Universitario Gregorio Maranon, Madrid, Spain

  • Department Of Psychiatry, University Medical Center Utrecht Brain Center, Utrecht University,Utrecht, Netherlands

  • Department of Psychiatry, Campania University “Luigi Vanvitelli”, Naples, Italy

  • Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark

  • Psychiatry, 12 de Octubre Hospital Research Institute, CIBERSAM, Madrid, Spain

  • Child And Adolescent Department Of Psychiatry, Hospital General Universitario Gregorio Marañón, Madrid, Spain

  • Department Of Psychiatry And Psychotherapy, School of Medicine, Technical University Munich, Munich, Germany

  • Psychosis Studies, Kings College London, London, United Kingdom

  • Psychiatry, The Mount Sinai Hospital, New York, United States of America

Locations

  • Spain

  • Denmark

  • United States

  • Italy

  • United Kingdom

  • Netherlands

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Schizophrenia

  • Depression

Biomarkers

  • N/A

Drug/Treatment

  • Clozapine

Outcome

  • N/A


Study Design

  • Prospective

  • Cohort

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A